UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2019
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 001-38937
Mohawk Group Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
83-1739858 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer |
37 East 18th Street, 7th Floor New York, NY |
|
10003 |
(Address of principal executive offices) |
|
(Zip Code) |
(347) 676-1681
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value per share |
|
MWK |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☒ |
Emerging growth company |
☒ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 5, 2019, the registrant had 17,710,659 shares of common stock, $0.0001 par value per share, outstanding.
Table of Contents
|
|
Page |
PART I. |
|
|
Item 1. |
1 |
|
|
1 |
|
|
2 |
|
|
3 |
|
|
4 |
|
|
6 |
|
|
Notes to Unaudited Condensed Consolidated Financial Statements |
7 |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
22 |
Item 3. |
36 |
|
Item 4. |
36 |
|
PART II. |
|
|
Item 1. |
38 |
|
Item 1A. |
38 |
|
Item 2. |
68 |
|
Item 3. |
68 |
|
Item 4. |
68 |
|
Item 5. |
68 |
|
Item 6. |
69 |
|
70 |
i
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risk and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:
|
• |
our future financial performance, including our revenue, costs of goods sold and operating expenses; |
|
• |
our ability to achieve and grow profitability; |
|
• |
the sufficiency of our cash to meet our liquidity needs and to execute our growth strategies; |
|
• |
our ability to maintain the security and availability of our technology platform, including our AIMEE (Artificial Intelligence Mohawk e-Commerce Engine) software platform; |
|
• |
our ability to successfully launch new products; |
|
• |
our ability to identify and complete merger and acquisition transactions; |
|
• |
our predictions about industry and market trends; |
|
• |
our ability to successfully expand internationally; |
|
• |
our ability to effectively manage our growth and future expenses; |
|
• |
our estimated total addressable market; |
|
• |
our ability to maintain, protect and enhance our intellectual property, including our AIMEE software platform; |
|
• |
our ability to comply with modified or new laws and regulations applying to our business; |
|
• |
the attraction and retention of qualified employees and key personnel; |
|
• |
our ability to successfully defend litigation brought against us; and |
|
• |
the increased expenses and obligations associated with being a public company. |
We caution you that the foregoing list may not contain all the forward-looking statements made in this Quarterly Report on Form 10-Q.
We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section of this Quarterly Report on Form 10-Q entitled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and challenging environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. We cannot assure you that the results, events and circumstances reflected, or that the plans, intentions or expectations disclosed, in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.
ii
MOHAWK GROUP HOLDINGS, INC.
Condensed Consolidated Balance Sheets
(Unaudited)
(in thousands, except share and per share data)
|
|
December 31, 2018 |
|
|
September 30, 2019 |
|
||
|
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
20,029 |
|
|
$ |
35,686 |
|
Accounts receivable—net |
|
|
1,403 |
|
|
|
3,152 |
|
Inventory |
|
|
30,552 |
|
|
|
25,908 |
|
Prepaid and other current assets |
|
|
5,418 |
|
|
|
6,736 |
|
Total current assets |
|
|
57,402 |
|
|
|
71,482 |
|
PROPERTY AND EQUIPMENT—net |
|
|
268 |
|
|
|
140 |
|
GOODWILL AND OTHER INTANGIBLES—net |
|
|
— |
|
|
|
1,071 |
|
OTHER NON-CURRENT ASSETS |
|
|
337 |
|
|
|
135 |
|
TOTAL ASSETS |
|
$ |
58,007 |
|
|
$ |
72,828 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Credit facility |
|
$ |
14,451 |
|
|
$ |
13,640 |
|
Accounts payable |
|
|
15,404 |
|
|
|
15,453 |
|
Accrued and other current liabilities |
|
|
9,708 |
|
|
|
10,880 |
|
Total current liabilities |
|
|
39,563 |
|
|
|
39,973 |
|
OTHER LIABILITIES |
|
|
26 |
|
|
|
8 |
|
TERM LOANS |
|
|
13,049 |
|
|
|
13,339 |
|
Total liabilities |
|
|
52,638 |
|
|
|
53,320 |
|
COMMITMENTS AND CONTINGENCIES (Note 9) |
|
|
|
|
|
|
|
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
|
|
Common stock, par value $0.0001 per share—500,000,000 shares authorized and 11,534,190 shares outstanding at December 31, 2018; 500,000,000 shares authorized and 17,710,659 shares outstanding at September 30, 2019 |
|
|
1 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
76,348 |
|
|
|
117,791 |
|
Accumulated deficit |
|
|
(71,020 |
) |
|
|
(98,351 |
) |
Accumulated other comprehensive income |
|
|
40 |
|
|
|
66 |
|
Total stockholders’ equity |
|
|
5,369 |
|
|
|
19,508 |
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
$ |
58,007 |
|
|
$ |
72,828 |
|
See notes to condensed consolidated financial statements.
1
Condensed Consolidated Statements of Operations
(Unaudited)
(in thousands, except share and per share data)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
2018 |
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|||||
NET REVENUE |
|
$ |
24,672 |
|
|
$ |
40,603 |
|
|
$ |
53,576 |
|
|
$ |
88,817 |
|
COST OF GOODS SOLD |
|
|
14,262 |
|
|
|
23,076 |
|
|
|
35,919 |
|
|
|
52,859 |
|
GROSS PROFIT |
|
|
10,410 |
|
|
|
17,527 |
|
|
|
17,657 |
|
|
|
35,958 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
11,560 |
|
|
|
17,307 |
|
|
|
28,516 |
|
|
|
38,409 |
|
Research and development |
|
|
790 |
|
|
|
2,634 |
|
|
|
2,810 |
|
|
|
5,657 |
|
General and administrative |
|
|
2,767 |
|
|
|
7,999 |
|
|
|
8,103 |
|
|
|
15,779 |
|
TOTAL OPERATING EXPENSES: |
|
|
15,117 |
|
|
|
27,940 |
|
|
|
39,429 |
|
|
|
59,845 |
|
OPERATING LOSS |
|
|
(4,707 |
) |
|
|
(10,413 |
) |
|
|
(21,772 |
) |
|
|
(23,887 |
) |
INTEREST EXPENSE—net |
|
|
439 |
|
|
|
875 |
|
|
|
1,503 |
|
|
|
3,368 |
|
OTHER EXPENSE (INCOME)—net |
|
|
(19 |
) |
|
|
21 |
|
|
|
(45 |
) |
|
|
53 |
|
LOSS BEFORE INCOME TAXES |
|
|
(5,127 |
) |
|
|
(11,309 |
) |
|
|
(23,230 |
) |
|
|
(27,308 |
) |
PROVISION FOR INCOME TAXES |
|
|
— |
|
|
|
8 |
|
|
|
3 |
|
|
|
23 |
|
NET LOSS |
|
$ |
(5,127 |
) |
|
$ |
(11,317 |
) |
|
$ |
(23,233 |
) |
|
$ |
(27,331 |
) |
Net loss per share, basic and diluted |
|
$ |
(0.49 |
) |
|
$ |
(0.75 |
) |
|
$ |
(2.40 |
) |
|
$ |
(2.11 |
) |
Weighted-average number of shares outstanding, basic and diluted |
|
|
10,532,926 |
|
|
|
15,134,422 |
|
|
|
9,687,078 |
|
|
|
12,971,641 |
|
See notes to condensed consolidated financial statements.
2
Condensed Consolidated Statements of Comprehensive Loss
(Unaudited)
(in thousands)
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|||||||||||
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
||||
NET LOSS |
|
$ |
(5,127 |
) |
|
$ |
(11,317 |
) |
|
$ |
(23,233 |
) |
|
$ |
(27,331 |
) |
OTHER COMPREHENSIVE INCOME (LOSS): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
(19 |
) |
|
|
13 |
|
|
|
57 |
|
|
|
26 |
|
Other comprehensive income (loss) |
|
|
(19 |
) |
|
|
13 |
|
|
|
57 |
|
|
|
26 |
|
COMPREHENSIVE LOSS |
|
$ |
(5,146 |
) |
|
$ |
(11,304 |
) |
|
$ |
(23,176 |
) |
|
$ |
(27,305 |
) |
3
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)
(in thousands, except share and per share data)
|
|
Three Months Ended September 30, 2018 |
|
|||||||||||||||||||||
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders’ Equity |
|
|||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Income/(Loss) |
|
|
(Deficit) |
|
||||||
BALANCE—July 1, 2018 |
|
|
10,117,017 |
|
|
$ |
1 |
|
|
$ |
68,741 |
|
|
$ |
(57,303 |
) |
|
$ |
33 |
|
|
$ |
11,472 |
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,127 |
) |
|
|
— |
|
|
|
(5,127 |
) |
Issuance of 5,992,750 shares of series C preferred stock in April 2018 which converted at 0.2564 per share into 1,536,602 shares of common stock as part of the Merger (see Note 1) |
|
|
|
|
|
|
— |
|
|
|
(17 |
) |
|
|
— |
|
|
|
— |
|
|
|
(17 |
) |
Issuance of 1,915,916 shares of series C-1 preferred stock in September 2018 which converted at 0.2564 per share into 491,260 shares of common stock as part of the Merger (see Note 1) |
|
|
491,260 |
|
|
|
— |
|
|
|
6,417 |
|
|
|
— |
|
|
|
— |
|
|
|
6,417 |
|
Issuance of common stock as part of the Merger (see Note 1) |
|
|
897,435 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of common stock to holders of series B preferred stock for anti-dilution rights as part of the Merger (see Note 1) |
|
|
28,478 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
141 |
|
|
|
— |
|
|
|
— |
|
|
|
141 |
|
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(19 |
) |
|
|
(19 |
) |
BALANCE—September 30, 2018 |
|
|
11,534,190 |
|
|
$ |
1 |
|
|
$ |
75,282 |
|
|
$ |
(62,430 |
) |
|
$ |
14 |
|
|
$ |
12,867 |
|
|
|
Three Months Ended September 30, 2019 |
|
|||||||||||||||||||||
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders’ Equity |
|
||||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Income/(Loss) |
|
|
(Deficit) |
|
||||||
BALANCE—July 1, 2019 |
|
|
17,625,241 |
|
|
$ |
2 |
|
|
$ |
110,094 |
|
|
$ |
(87,034 |
) |
|
$ |
53 |
|
|
$ |
23,115 |
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(11,317 |
) |
|
|
— |
|
|
|
(11,317 |
) |
Issuance costs from Initial Public Offering |
|
|
|
|
|
|
— |
|
|
|
(21 |
) |
|
|
— |
|
|
|
— |
|
|
|
(21 |
) |
Issuance of 84,975 share of restricted common stock in August 2019 (see Note 7) |
|
|
84,975 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
7,716 |
|
|
|
— |
|
|
|
— |
|
|
|
7,716 |
|
Exercise of stock options |
|
|
443 |
|
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13 |
|
|
|
13 |
|
BALANCE—September 30, 2019 |
|
|
17,710,659 |
|
|
$ |
2 |
|
|
$ |
117,791 |
|
|
$ |
(98,351 |
) |
|
$ |
66 |
|
|
$ |
19,508 |
|
4
|
|
Nine Months Ended September 30, 2018 |
|
|||||||||||||||||||||
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders’ Equity |
|
|||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Income/(Loss) |
|
|
(Deficit) |
|
||||||
BALANCE—January 1, 2018 |
|
|
8,575,950 |
|
|
$ |
1 |
|
|
$ |
47,393 |
|
|
$ |
(39,197 |
) |
|
$ |
(43 |
) |
|
$ |
8,154 |
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23,233 |
) |
|
|
— |
|
|
|
(23,233 |
) |
Issuance of 5,992,750 shares of series C preferred stock in April 2018 which converted at 0.2564 per share into 1,536,602 shares of common stock as part of the Merger (see Note 1) |
|
|
1,536,602 |
|
|
|
— |
|
|
|
20,972 |
|
|
|
— |
|
|
|
— |
|
|
|
20,972 |
|
Issuance of 1,915,916 shares of series C-1 preferred stock in September 2018 which converted at 0.2564 per share into 491,260 shares of common stock as part of the Merger (see Note 1) |
|
|
491,260 |
|
|
|
— |
|
|
|
6,417 |
|
|
|
— |
|
|
|
— |
|
|
|
6,417 |
|
Issuance of common stock as part of the Merger (see Note 1) |
|
|
897,435 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of common stock to holders of series B preferred stock for anti-dilution rights as part of the Merger (see Note 1) |
|
|
28,478 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
482 |
|
|
|
— |
|
|
|
— |
|
|
|
482 |
|
Exercise of stock options |
|
|
4,465 |
|
|
|
— |
|
|
|
18 |
|
|
|
— |
|
|
|
— |
|
|
|
18 |
|
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
57 |
|
|
|
57 |
|
BALANCE—September 30, 2018 |
|
|
11,534,190 |
|
|
$ |
1 |
|
|
$ |
75,282 |
|
|
$ |
(62,430 |
) |
|
$ |
14 |
|
|
$ |
12,867 |
|
|
|
Nine Months Ended September 30, 2019 |
|
|||||||||||||||||||||
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders’ Equity |
|
|||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Income/(Loss) |
|
|
(Deficit) |
|
||||||
BALANCE—January 1, 2019 |
|
|
11,534,190 |
|
|
$ |
1 |
|
|
$ |
76,348 |
|
|
$ |
(71,020 |
) |
|
$ |
40 |
|
|
$ |
5,369 |
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(27,331 |
) |
|
|
— |
|
|
|
(27,331 |
) |
Issuance of 2,406,618 shares of restricted common stock on March 20, 2019 (see Note 7) |
|
|
2,406,618 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of 88,548 shares of restricted common stock on May 17, 2019 and forfeiture of 69,141 shares of restricted common stock (see Note 7) |
|
|
19,407 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of 64,982 shares of restricted common stock on June 12, 2019 (see Note 7) |
|
|
64,982 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of 3,600,000 shares of common stock on June 14, 2019 (see Note 1) |
|
|
3,600,000 |
|
|
|
1 |
|
|
|
29,606 |
|
|
|
— |
|
|
|
— |
|
|
|
29,607 |
|
Issuance of 84,975 share of restricted common stock in August 2019 (see Note 7) |
|
|
84,975 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
11,835 |
|
|
|
— |
|
|
|
— |
|
|
|
11,835 |
|
Exercise of stock options |
|
|
487 |
|
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
26 |
|
|
|
26 |
|
BALANCE—September 30, 2019 |
|
|
17,710,659 |
|
|
$ |
2 |
|
|
$ |
117,791 |
|
|
$ |
(98,351 |
) |
|
$ |
66 |
|
|
$ |
19,508 |
|
See notes to condensed consolidated financial statements.
5
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)
|
|
Nine Months Ended September 30, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(23,233 |
) |
|
$ |
(27,331 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
188 |
|
|
|
136 |
|
Provision for sales returns |
|
|
128 |
|
|
|
236 |
|
Amortization of deferred financing costs and debt discounts |
|
|
337 |
|
|
|
914 |
|
Stock-based compensation |
|
|
482 |
|
|
|
11,835 |
|
Other |
|
|
62 |
|
|
|
101 |
|
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
48 |
|
|
|
(1,784 |
) |
Inventory |
|
|
(515 |
) |
|
|
4,944 |
|
Prepaid and other current assets |
|
|
(2,757 |
) |
|
|
(2,307 |
) |
Accounts payable, accrued and other liabilities |
|
|
5,731 |
|
|
|
110 |
|
Cash used in operating activities |
|
|
(19,529 |
) |
|
|
(13,146 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchase of fixed assets |
|
|
(25 |
) |
|
|
(48 |
) |
Purchase of Aussie Health Co. assets |
|
|
— |
|
|
|
(1,105 |
) |
Proceeds on sale of fixed assets |
|
|
35 |
|
|
|
6 |
|
Cash provided by (used in) investing activities |
|
|
10 |
|
|
|
(1,147 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
— |
|
|
|
2 |
|
Proceeds from issuance of Series C preferred stock - converted to common stock |
|
|
23,061 |
|
|
|
— |
|
Proceeds from issuance of Series C-1 preferred stock - converted to common stock |
|
|
8,364 |
|
|
|
— |
|
Proceeds from Initial Public Offering |
|
|
— |
|
|
|
36,000 |
|
Proceeds received from exercise of stock options |
|
|
18 |
|
|
|
— |
|
Issuance costs of Series C preferred stock - converted to common stock |
|
|
(3,000 |
) |
|
|
— |
|
Issuance costs of Series C-1 preferred stock - converted to common stock |
|
|
(1,036 |
) |
|
|
— |
|
Issuance costs from initial public offering |
|
|
— |
|
|
|
(5,446 |
) |
Borrowings from Mid Cap credit facility |
|
|
37,048 |
|
|
|
69,740 |
|
Repayments from Mid Cap credit facility |
|
|
(32,519 |
) |
|
|
(71,082 |
) |
Repayments from Mid Cap term loan |
|
|
(1,344 |
) |
|
|
— |
|
Debt issuance costs from Mid Cap credit facility |
|
|
(369 |
) |
|
|
(581 |
) |
Debt issuance costs from Horizon term loan |
|
|
— |
|
|
|
(900 |
) |
Deferred offering costs |
|
|
(17 |
) |
|
|
— |
|
Insurance financing proceeds |
|
|
— |
|
|
|
3,833 |
|
Insurance obligation payments |
|
|
— |
|
|
|
(1,818 |
) |
Capital lease financing proceeds |
|
|
20 |
|
|
|
— |
|
Capital lease obligation payments |
|
|
(40 |
) |
|
|
(42 |
) |
Cash provided by financing activities |
|
|
30,186 |
|
|
|
29,706 |
|
EFFECT OF EXCHANGE RATE ON CASH |
|
|
— |
|
|
|
1 |
|
NET CHANGE IN CASH AND RESTRICTED CASH FOR PERIOD |
|
|
10,667 |
|
|
|
15,414 |
|
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD |
|
|
5,797 |
|
|
|
20,708 |
|
CASH AND RESTRICTED CASH AT END OF PERIOD |
|
$ |
16,464 |
|
|
$ |
36,122 |
|
RECONCILIATION OF CASH AND RESTRICTED CASH |
|
|
|
|
|
|
|
|
CASH |
|
$ |
15,785 |
|
|
$ |
35,686 |
|
RESTRICTED CASH—Prepaid and other assets |
|
|
550 |
|
|
|
307 |
|
RESTRICTED CASH—Other non-current assets |
|
|
129 |
|
|
|
129 |
|
TOTAL CASH AND RESTRICTED CASH |
|
$ |
16,464 |
|
|
$ |
36,122 |
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
1,112 |
|
|
$ |
2,467 |
|
Cash paid for taxes |
|
$ |
3 |
|
|
$ |
15 |
|
NON-CASH INVESTING AND FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Capital lease |
|
$ |
25 |
|
|
$ |
— |
|
Note payable on acquisition |
|
|
|
|
|
$ |
195 |
|
See notes to condensed consolidated financial statements.
6
Notes to condensed consolidated financial statements
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 and 2019 (Unaudited)
(In thousands, except share and per share data)
1. |
ORGANIZATION AND DESCRIPTION OF BUSINESS |
Mohawk Group Holdings, Inc. and subsidiaries (“Mohawk” or the “Company”) is a rapidly growing technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market and sell products. Mohawk predominately operates through online retail channels such as Amazon and Walmart.
Headquartered in New York, Mohawk’s offices can be found in China, Philippines, Israel, Poland, and the United States.
Merger—On September 4, 2018, pursuant to an Agreement and Plan of Merger and Reorganization among the Company, MGH Merger Sub, Inc. and Mohawk Group, Inc. (“MGI”), as amended by Amendment No. 1 dated as of April 1, 2018 (the “Merger Agreement”), MGI merged with Merger Sub, Inc., with MGI remaining as the surviving entity and becoming a wholly-owned operating subsidiary of the Company (the “Merger”). The Merger was a reverse recapitalization for financial reporting purposes. The Merger is reflected in the financial statements and financial disclosures as if the Merger was effective on January 1, 2017. Operations prior to the Merger are the historical operations of MGI.
Under the Merger Agreement, all outstanding shares of common stock, shares of preferred stock and warrants, excluding MGI’s Series C preferred stock (“Series C”) and warrants to purchase shares of Series C, converted to shares of common stock of the Company at a ratio of 1 to 0.3131 (the “Conversion”). All outstanding Series C converted on a 1 to 0.2564 basis to shares of common stock of the Company and all outstanding warrants to purchase shares of Series C converted to warrants to purchase shares of common stock of the Company on a 1 to 0.2564 basis. At the time of the merger, the Company had 0.9 million shares outstanding held by certain Series C holders.
Initial Public Offering—On June 14, 2019, the Company completed its initial public offering (“IPO”), selling 3,600,000 shares of common stock at a public offering price of $10.00 per share. Net proceeds to the Company from the offering were approximately $29.6 million, after deducting legal, underwriting and other offering expenses.
Liquidity, Going Concern and Initial Public Offering—The Company is an early-stage growth company. As a result, the Company is investing in launching new products, advancing its software, and its sales and distribution infrastructure to accelerate revenue growth and scale operations to support such growth. To fund this investment, the Company has incurred losses with the expectation that it will generate profitable revenue streams in the future. While management and the Company’s board of directors believes that the Company will eventually reach a scale where the growth of its product revenues will offset the continued investments required in launching new products, completing the development of its software, and managing its sales and distribution operations, they believe that the size and nascent stage of the Company’s target market justify continuing to invest in growth at the expense of short-term profitability.
In pursuit of the foregoing growth strategy, the Company incurred operating losses of $22.6 million and $29.4 million for the years ended December 31, 2017 and 2018, respectively, primarily due to the impact from its continued investment in launching new products, advancing its AIMEE software platform and building out its sales and distribution infrastructure. In addition, at December 31, 2017 and 2018, the Company had an accumulated deficit of $39.2 million and $71.0 million, respectively, cash on hand amounted to $5.3 million and $20.0 million, respectively, total outstanding borrowings from lenders amounted to $10.3 million and $27.5 million, respectively, and total available capacity on borrowings amounted to $5.6 million and $1.4 million at December 31, 2017 and 2018, respectively. Moreover, the Company has not had a sufficient track record of improvement of its operating cash outflows. As such, in the event that the Company was unsuccessful in its ability to continue to reduce its cash outflows or obtain additional financing if such reduction in cash outflows was not achieved, the Company would have been unable to meet its obligations as they became due within one year from the date these condensed consolidated financial statements were issued. These negative financial conditions raised substantial doubt about the Company’s ability to continue as a going concern.
7
Management plans to continue pursuing its growth strategy. In the past, the Company has successfully funded its losses to-date through equity financings, beginning in July 2014. As of December 31, 2018, the Company has raised over $72.6 million in equity financing to fund its operations since inception. Further, in October 2017, the Company improved its working capital flexibility by securing a $15 million credit facility (which could be incre